Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stoke Therapeutics (STOK) Other Operating Expenses (2024 - 2025)

Stoke Therapeutics (STOK) has 2 years of Other Operating Expenses data on record, last reported at -$152.4 million in Q3 2025.

  • For Q3 2025, Other Operating Expenses fell 15236800.0% year-over-year to -$152.4 million; the TTM value through Sep 2025 reached -$302.7 million, down 30268600.0%, while the annual FY2024 figure was -$150.3 million, N/A changed from the prior year.
  • Other Operating Expenses reached -$152.4 million in Q3 2025 per STOK's latest filing, down from -$150.3 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at -$1000.0 in Q3 2024 and bottomed at -$152.4 million in Q3 2025.